RenovaCare products are under development and not approved for sale in the United States.

Results my vary from person to person.

RenovaCare products are under development and not approved for sale in the United States.
Results may vary from person to person.

RenovaCare, Inc. Enters R&D Partnership with World Leading Charité

New York & Pittsburgh, PA – November 17, 2015 – RenovaCare, Inc. (OTCQB: RCAR), today announced a partnership to validate the science behind its groundbreaking technology for treatments of wounds, burns and other skin defects. The company’s research partner is Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charité – Universitätsmedizin Berlin,…

Featured On National Geographic

The SkinGun™ is profiled on National Geographic. Click here to watch the video at natgeo.com (opens in a new tab or window). RenovaCare’s patented SkinGun™ spray device is the world’s most advanced technology of its kind. As part of our groundbreaking CellMist™ System, it has shown in early clinical observations in the United States and…

RenovaCare, Inc. and StemCell Systems GmbH: Collaborators for Breakthrough Development

RenovaCare has joined forces with StemCell Systems GmbH, one of Germany’s leading firms in the field of technologies for regenerative medicine, to advance its CellMist™ System and SkinGun™ delivery device toward commercial release. StemCell Systems invents and engineers biomedical devices for regenerative medicine. Based in Berlin, Germany, their engineering services are geared toward providing innovation…